¥14.70
¥-0.41 (-2.79%)
End-of-day quote: 05/14/2024
SHSE:688315
Novogene Annual Report
| Year | Year | 2023 | 2022 | 2021 | ||
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥2.00B | ¥1.93B | ¥1.87B | |
| GM % | Gross Margin % |
|
42.58% | 44.09% | 42.54% | |
| OM | Operating Margin |
|
8.84% | 10.44% | 10.75% | |
| EPS | Earnings Per Share |
|
¥0.00 | ¥0.35 | ¥0.38 | ¥0.45 |
| Div. | Dividends |
|
¥0.05 | ¥0.05 | ¥0.00 | |
| PR % | Payout Ratio % |
|
14.29% | 13.16% | 0 | |
| Sha. | Shares |
|
416.2m | 400.2m | 400.2m | |
| OCF | Operating Cash Flow |
|
¥334.20M | ¥303.95M | ¥293.47M | |
| FCF | Free Cash Flow |
|
¥-9.59M | ¥86.73M | ¥184.41M | |
| FCFS | Free Cash Flow Per Share |
|
¥0.54 | ¥0.22 | ¥0.47 |
